靶向糖酵解酶PGK1抑制Warburg效应:瘢痕疙瘩治疗的新策略
研究检测瘢痕疙瘩组织中磷酸甘油酸激酶1(PGK1)的表达,并在常氧和缺氧条件下观察抑制PGK1对瘢痕疙瘩成纤维细胞的影响。免疫组化显示瘢痕疙瘩组织PGK1过表达(P<0.05),敲低PGK1可抑制瘢痕疙瘩成纤维细胞糖酵解、增殖、迁移、侵袭及葡萄糖消耗和乳酸生成(P<0.05),并可能经PI3K/AKT通路下调GLUT1、LDHA和COL1表达。
要点
- 瘢痕疙瘩组织中PGK1表达高于正常皮肤组织(P<0.05)。
- 缺氧刺激瘢痕疙瘩成纤维细胞和正常皮肤成纤维细胞PGK1表达(P<0.05)。
- 敲低PGK1抑制瘢痕疙瘩成纤维细胞糖酵解、增殖、迁移和侵袭(P<0.05)。
核心结论
- 抑制PGK1可抑制糖酵解,减少瘢痕疙瘩成纤维细胞增殖、迁移、侵袭及I型胶原表达。
- 靶向PGK1抑制Warburg效应可能成为瘢痕疙瘩的新治疗策略。
研究设计与样本
- 研究将正常皮肤和瘢痕疙瘩样本分为两部分,一部分用于免疫组化,一部分用于原代细胞培养。
- 采用逆转录聚合酶链反应和蛋白质印迹检测PGK1、GLUT1、LDHA和COL1表达,用酶标仪检测葡萄糖摄取和乳酸生成。
- 采用IncuCyte和流式细胞术检测细胞增殖和凋亡,Transwell实验检测细胞迁移和侵袭,Seahorse XF96系统检测糖酵解功能。
主要发现
- 免疫组化显示瘢痕疙瘩组织PGK1过表达,与正常皮肤组织比较P<0.05。
- 瘢痕疙瘩成纤维细胞PGK1表达显著高于正常皮肤成纤维细胞,缺氧刺激瘢痕疙瘩成纤维细胞和正常皮肤成纤维细胞PGK1表达,P<0.05。
- 敲低PGK1显著抑制瘢痕疙瘩成纤维细胞糖酵解、增殖、迁移、侵袭、葡萄糖消耗和乳酸生成,P<0.05。
- 与正常皮肤成纤维细胞比较,瘢痕疙瘩成纤维细胞中GLUT1、LDHA和COL1表达降低,P<0.05。
- 抑制PGK1可能通过PI3K/AKT通路下调GLUT1、LDHA和COL1表达,P<0.05。
临床怎么用
- 作者认为靶向PGK1抑制Warburg效应可能成为瘢痕疙瘩的新治疗策略。
- 本文可能为瘢痕疙瘩的发病机制和治疗提供新建议。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Aerobic glycolysis (the Warburg effect) may play an important role in keloid pathogenesis, which may be aggravated by the hypoxic microenvironment in keloids. Phosphoglycerate kinase 1 (PGK1), a key glycolytic enzyme, is essential for cellular aerobic glycolysis, but its role in keloid formation remains unknown. This study aimed to detect PGK1 expression in keloid tissue and investigate the effects of inhibiting PGK1 expression on keloid fibroblasts (KFbs) under hypoxia and normoxia. METHODS: Normal skin and keloid samples were separated into two parts, one was used for immunohistochemistry, and one for primary cell culture. PGK1 tissue expression was detected by immunohistochemistry. Reverse-transcriptase polymerase chain reaction and Western blotting were used to detect PGK1, GLUT1, LDHA, and COL1 expression, and glucose uptake and lactate production were detected with a microplate reader. Cell proliferation and apoptosis were investigated with IncuCyte and flow cytometry. Cell migration and invasion were detected with Transwell assays. Glycolytic function was explored with the Seahorse XF96 system. RESULTS: Immunohistochemistry showed PGK1 overexpression in keloid tissue compared with normal skin tissue ( P < 0.05). Consistently, PGK1 expression was significantly higher in KFbs than in normal skin fibroblasts (NFbs), and hypoxia stimulated PGK1 expression in KFbs and NFbs ( P < 0.05). PGK1 knockdown significantly inhibited KFb glycolysis, proliferation, migration, invasion, glucose consumption, and lactate production ( P < 0.05). Furthermore, GLUT1, LDHA, and COL1 expression was decreased in KFbs compared with NFbs ( P < 0.05). In addition, suppressing PGK1 may mediate the PI3K/AKT pathway to down-regulate GLUT1, LDHA, and COL1 expression ( P < 0.05). CONCLUSIONS: These findings provide new evidence that suppressing PGK1, inhibiting glycolysis, reduces KFb proliferation, migration, invasion, and type I collagen expression. Targeting PGK1 to inhibit the Warburg effect may be a new therapeutic strategy for keloids. CLINICAL RELEVANCE STATEMENT: This article may provide new suggestions into the pathogenesis and treatment of keloids. CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, V.
引用
- Wang P, Wang Q, Yang X, et al. Targeting the Glycolytic Enzyme PGK1 to Inhibit the Warburg Effect: A New Strategy for Keloid Therapy. Plast Reconstr Surg. 2023. PMID: 36728674. doi:10.1097/PRS.0000000000010137
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。